• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

eoflow

Insulet earns insulin patch pump patent victory against EOFlow with permanent injunction

April 29, 2025 By Sean Whooley

Medtronic EOFlow EOPatch Insulet Omnipod 5

A judge has issued a permanent injunction, signaling an Insulet (Nasdaq:PODD) victory in a trade secret case against EOFlow. The permanent injunction highlights the successful defense of Insulet’s intellectual property. Subsequently, the damages award was reduced from $452 million to $60 million at Insulet’s election. The company wanted the permanent injunction instead of the higher […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News, Regulatory/Compliance, Technology Tagged With: eoflow, Insulet

Insulet prevails in IP battle with patch pump maker EOFlow

December 5, 2024 By Sean Whooley

Medtronic EOFlow EOPatch Insulet Omnipod 5

Insulet (Nasdaq:PODD) announced that it successfully defended its intellectual property against EOFlow in U.S. federal court. Both companies develop automated insulin delivery systems utilizing patch pump technology. Insulet offers the market-leading Omnipod platform, while Korea-based EOFlow develops the EOPatch — similarly, a tubeless, wearable and fully disposable insulin delivery device. EOFlow was at one point […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News, Technology Tagged With: eoflow, Insulet

Former Medtronic acquisition target EOFlow to raise $61.5M, faces Insulet patent infringement lawsuit

August 22, 2024 By Sean Whooley

EOFlow EOPatch insulin patch

EOFlow faces a patent infringement lawsuit from fellow insulin patch pump maker Insulet as it attempts to bring in millions in a new funding round. The Korea-based company develops the EOPatch — a tubeless, wearable and fully disposable insulin delivery device. EOFlow was at one point set to be acquired by Medtronic for $738 million last […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Legal News, Technology Tagged With: eoflow, Insulet

Report: There’s still ‘mutual interest’ with EOFlow, Medtronic despite deal falling through

December 8, 2023 By Sean Whooley

EOFlow Logo

Business Korea reports that EOFlow CEO Kim Jae-jin is leaving the door open with regard to the company’s collapsed deal with Medtronic (NYSE:MDT). Medtronic announced this week that it terminated its $738 million agreement to acquire EOFlow, a maker of insulin patch pumps. The medtech giant cited “multiple breaches” of terms in the agreement as […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News, Mergers & Acquisitions, Technology Tagged With: eoflow, Insulet, Medtronic

Medtronic nixes $738M deal for insulin patch pump maker EOFlow

December 6, 2023 By Sean Whooley

EOFlow EOPatch insulin patch

Medtronic (NYSE:MDT) filed a Form 8K with the SEC today stating that it terminated its agreement to buy EOFlow. The medtech giant struck a $738 million deal to acquire the Seongnam, South Korea-based insulin patch pump maker in May. EOFlow develops the EOPatch — a tubeless, wearable and fully disposable insulin delivery device. Medtronic’s SEC filing […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Technology Tagged With: eoflow, Medtronic

Analysts still high on Insulet despite Medtronic’s EOFlow buy, stock market reaction

May 25, 2023 By Sean Whooley

Medtronic EOFlow EOPatch Insulet Omnipod 5

Despite a negative reaction from investors following a major buy in the insulin delivery space, analysts still back Insulet (Nasdaq:PODD) stock to perform. Shares of PODD fell throughout today after Medtronic (NYSE:MDT) announced a $738 million acquisition of EOFlow. Korea-based EOFlow develops the EOPatch, a tubless, wearable and fully disposable insulin delivery device. Insulet represents […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Wall Street Beat Tagged With: eoflow, Insulet, Medtronic

Medtronic to acquire wearable insulin patch maker EOFlow for $738M

May 25, 2023 By Sean Whooley

EOFlow EOPatch insulin patch

Medtronic (NYSE:MDT) announced today that it entered into a set of agreements to acquire insulin delivery technology developer EOFlow. Seongnam, South Korea-based EOFlow develops the EOPatch — a tubeless, wearable and fully disposable insulin delivery device. EOFlow already launched its EOPatch insulin delivery system in Korea and Europe. The company submitted the insulin delivery device […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Patient Monitoring, Technology Tagged With: eoflow, Medtronic

EOFlow invests $7.7B in Pharmeo subsidiary for non-insulin drug delivery development

February 16, 2023 By Sean Whooley

EOFlow EOPatch insulin patch

EOFlow announced today that it plans to invest $7.7 billion (9.9 billion Korean Won) in its wholly-owned Pharmeo subsidiary. The investment aims to advance R&D and commercialization of non-insulin drugs with EOFlow’s wearable drug delivery system. EOFlow intends to finance this investment through paid-in capital increase for the subsidiary. EOFlow owes the actual investment, totaling […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Technology Tagged With: eoflow, Pharmeo

The year ahead in diabetes care: what to expect in 2023

January 25, 2023 By Sean Whooley

Walmart Health Virtual Care Diabetes Program

After a banner year for diabetes technology in 2022, there’s still plenty to look forward to in 2023. Throughout 2022, we saw a wide range of advancements in diabetes technology. We saw launches for next-generation technologies, exciting clinical trial results, rumored spinouts and acquisitions and more. You can read all about the biggest diabetes stories […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Mergers & Acquisitions, Patient Monitoring, Pharmaceuticals, Regulatory/Compliance, Research & Development, Technology Tagged With: abbott, Beta Bionics, Dexcom, Diabetes, Eli Lilly, embecta, eoflow, Insulet, Medtronic, Novo Nordisk, oramedpharmaceuticals, Senseonics, Tandem Diabetes Care, Ypsomed

Diabeloop, EOFlow partner on wearable automated insulin delivery in Europe

January 12, 2023 By Sean Whooley

EOFlow EOPatch insulin patch

Diabeloop and EOFlow announced that they partnered to offer the latter’s EOPatch system with automated insulin delivery in Europe. This partnership combines the EOPatch, a third-party continuous glucose monitor (CGM) and Diabeloop’s automated insulin delivery algorithm. They all integrate into Diabeloop’s currently under-development smartphone app. Paris-based Diabeloop said in a news release that they also […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Diabeloop, eoflow

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS